Relevant bibliographies by topics / Topical Olopatadine (0.1%)

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Topical Olopatadine (0.1%)'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Topical Olopatadine (0.1%).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Topical Olopatadine (0.1%)"

1

Kumar L, Kiran, and M. S. Smitha Gowda. "Comparison of efficacy of topical alcaftadine (0.25%) versus olopatadine (0.1%) in allergic conjunctivitis." Indian Journal of Clinical and Experimental Ophthalmology 7, no. 4 (2022): 630–33. http://dx.doi.org/10.18231/j.ijceo.2021.126.

Full text
Abstract:
The most common atopic ocular condition in clinical practice is allergic conjunctivitis. One of the preferred treatment options for allergic Conjunctivitis is anti histamines eye drops. The study purpose is to compare the clinical efficacy between topical alcaftadine 0.25% and olopatadine hydrochloride 0.1% in allergic conjunctivitis patients.A prospective, randomized, open label, parallel group, comparative study was conducted on 60 Patients with bilateral allergic conjunctivitis (30 in each group) after taking an informed written consentand was evaluated from May 2018 to November 2018. Patie
APA, Harvard, Vancouver, ISO, and other styles
2

Prashant, Kumar, and Verma Anurag. "Comparative Research on the Effectiveness and Safety of LongActing Antihistamines in Allergic Conjunctivitis in Indian Patients: An RCT Trial." International Journal of Pharmaceutical and Clinical Research 13, no. 4 (2021): 181–87. https://doi.org/10.5281/zenodo.14201914.

Full text
Abstract:
<strong>Aim:</strong>&nbsp;The aim of the present study was to compare the safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.&nbsp;<strong>Methods:</strong>&nbsp;A total of 90 patients with mild or moderate allergic conjunctivitis were randomized into three groups with an allocation ratio of 1:1:1 using computer-generated random number sequence to receive topical anti-allergic medication for 14 days as Group 1: Topical 0.25% Alcaftadine eye drops OD, Group 2: Topical 0.2% Olopatadine eye drops OD and Group 3: Topic
APA, Harvard, Vancouver, ISO, and other styles
3

Renuka, Ranjan Alok, and Kumar Sinha Ajay. "Comparative Assessment of Alcaftadine 0.25%, Olopatadine Hydrochloride 0.2% and Bepotastine Besilate 1.5% as AntiAllergic Conjunctivitis Agents." International Journal of Pharmaceutical and Clinical Research 13, no. 6 (2021): 412–19. https://doi.org/10.5281/zenodo.14218171.

Full text
Abstract:
<strong>Aim:</strong>&nbsp;The aim of the present study to compare the safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis.&nbsp;<strong>Methods:&nbsp;</strong>A total of 90 patients with mild or moderate allergic conjunctivitis were randomized into three groups with an allocation ratio of 1:1:1 using computer‑generated random number sequence to receive topical anti-allergic medication for 14 days as Group 1: Topical 0.25% Alcaftadine eye drops OD, Group 2: Topical 0.2% Olopatadine eye drops OD and Group 3: Topical 1
APA, Harvard, Vancouver, ISO, and other styles
4

V. Manekar, Archana, and Sharayu Ashok Bhore. "A Comparative Study of Olopatadine Hydrochloride and Bepotastine Besilate in the Treatment of Allergic Conjunctivitis." International Journal of Research and Review 9, no. 3 (2022): 166–72. http://dx.doi.org/10.52403/ijrr.20220320.

Full text
Abstract:
Background -Ocular allergy is a commonly encountered pathology in clinical practice, which often is under diagnosed and consequently undertreated. These are rarely vision-threatening but can significantly decrease the quality of life for patients. Olopatadine and Bepotastine eyedrop have both antihistaminic and mast cell stabilization action. Their use can control acute symptoms and prevent relapses as well. We conducted this single blinded trial directly comparing the efficacy of the two topical anti allergic medications in mild forms of allergic conjunctivitis. Materials and Methods - A sing
APA, Harvard, Vancouver, ISO, and other styles
5

Katelaris, Constance H. "Topical olopatadine and loratadine compared with loratadine alone." Current Allergy and Asthma Reports 2, no. 4 (2002): 320. http://dx.doi.org/10.1007/s11882-002-0059-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Manoj, Kumar Mishra, Kumari Vaidehi, and K. Singh R. "A Comparative Study of Efficacy of Topical Olopatadine (0.1%), Bepotastine (1.5%) and Alcaftadine (0.25%) in Mild to Moderate Allergic Conjunctivitis at Sri Krishna Medical College, Muzaffarpur, Bihar, India." International Journal of Pharmaceutical and Clinical Research 14, no. 8 (2022): 553–59. https://doi.org/10.5281/zenodo.13357491.

Full text
Abstract:
<strong>Objectives:&nbsp;</strong>This study was to compare the safety and efficacy of topical Olopatadine (0.1%), Bepotastine (1.5%) and Alcaftadine (0.25%) in mild to moderate allergic conjunctivitis at Sri Krishna Medical College, Muzaffarpur, Bihar, India.&nbsp;<strong>Methods:&nbsp;</strong>All of the 150 cases were divided into three groups. Each group had 50 cases of allergic conjunctivitis. Group A: Patients were received topical 0.25% Alcaftadine eyedrops OD. Group B: Patients were received topical 0.2% Olopatadine eyedrops OD and Group C: Patients were received topical 1.5% Bepotasti
APA, Harvard, Vancouver, ISO, and other styles
7

Jagarlamudi, Anup, E. Anushree, Soma Harika, K. Kavya Sri, and Ch Rohit. "A simple randomized comparative study to evaluate the efficacy of 0.7% w/v Olopatadine hydrochloride ophthalmic solution and the Fixed Dose Combination of 0.1% w/v Olopatadine hydrochloride and 0.4% w/v Ketorolac tromethamine ophthalmic solution for the." Journal of Drug Delivery and Therapeutics 9, no. 3 (2019): 279–85. http://dx.doi.org/10.22270/jddt.v9i3.2657.

Full text
Abstract:
Conjunctivitis is defined as the inflammation of the conjunctiva. Allergic conjunctivitis is an acute, intermittent or chronic inflammation of the conjunctiva due to air borne allergens. Allergic reactions occur when the immune system is hypersensitive to normally harmless environmental substances, called allergens. Allergic conjunctivitis is an increasingly prevalent allergic reaction and currently 40% of global population is suffering from allergic conjunctivitis. Being an immunopathological disease, Conjunctival mast cell degranulation plays a major role in ocular allergic disease and so tr
APA, Harvard, Vancouver, ISO, and other styles
8

Gupta, Pranav, Etti Goyal, and Jaya Devendra. "Comparative Study of 0.1% Olopatadine vs 0.05% Cyclosporine in Patients of Recalcitrant Vernal Keratoconjunctivitis." International Journal of Advanced and Integrated Medical Sciences 1, no. 4 (2016): 139–42. http://dx.doi.org/10.5005/jp-journals-10050-10048.

Full text
Abstract:
ABSTRACT Introduction Vernal keratoconjunctivitis (VKC) is a chronic, recurrent, bilateral inflammatory disease showing exacerbations during the spring and summer seasons, affecting young children. Present study was conducted with the aim of comparing the efficacy of cyclosporine 0.05% with olopatadine 0.1% in recalcitrant patients of VKC. Materials and methods A prospective randomized controlled trial was performed on 40 eyes (20 patients of recalcitrant VKC) during the period of May 2015 to September 2015. A short course of mild steroid was given for 5 days to all patients as they presented
APA, Harvard, Vancouver, ISO, and other styles
9

Sujata, Kumari, Garg Gautam, Kumar Naveen, and Kumar Sunil. "A Prospective Single Centre Clinical Trial Assessing Alcaftadine (0.25%) with Olopatadine (0.2%) in Allergic Conjunctivitis." International Journal of Current Pharmaceutical Review and Research 16, no. 2 (2024): 132–36. https://doi.org/10.5281/zenodo.10976397.

Full text
Abstract:
Aim: The aim of the present study was to compare the alcaftadine (0.25%) with olopatadine (0.2%) in allergicconjunctivitis.Methods: This was a prospective, observer masked, single centre clinical trial conducted in the Department ofOphthalmology for the period of one year.adhered to the principles of the declaration of Helsinki. Informedconsent was obtained from all the participants. 200 patients were enrolled in the study.Results: 100 patients received alcaftadine 0.25 % eye drop and 100 patients received olopatadine 0.2 % eye drop.Mean age of alcaftadine 0.25 % treated group was 26 &plusmn;
APA, Harvard, Vancouver, ISO, and other styles
10

Skorokhodkina, O. V., D. A. Volkova, A. V. Luntsov, M. R. Khakimova, and A. R. Valeeva. "Selecting an optimal pharmacotherapy for allergic rhinitis from the standpoint of guidelines and observation in real-life clinical practice." Meditsinskiy sovet = Medical Council, no. 7 (May 5, 2023): 80–88. http://dx.doi.org/10.21518/ms2023-058.

Full text
Abstract:
Introduction. Allergic rhinitis (AR) is a common condition that has considerable impact on patients’ quality of life. Moreover, it is the risk factor for asthma development. Therefore, achieving control of AR remains crucial.Aim. To analyze comparative efficacy of fixed-dose combination of olopatadine hydrochloride – mometasone furoate versus combination of intranasal corticosteroids with second generation oral antihistamines.Materials and methods. Seventy-five patients (ages 19–59) mainly with moderate severity of AR enrolled the study. Group 1 (29 patients) was given a fixed-dose combination
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Topical Olopatadine (0.1%)"

1

Bigelow, Dyk Melinda Michelle. "Determinants of human exposure to Fipronil following use as a topical flea and tick treatment of companion animals." Diss., UC access only, 2009. http://proquest.umi.com/pqdweb?index=44&did=1905733921&SrchMode=1&sid=2&Fmt=7&retrieveGroup=0&VType=PQD&VInst=PROD&RQT=309&VName=PQD&TS=1270145414&clientId=48051.

Full text
Abstract:
Thesis (Ph. D.)--University of California, Riverside, 2009.<br>Includes abstract. Includes bibliographical references (leaves 201-210). Issued in print and online. Available via ProQuest Digital Dissertations.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Topical Olopatadine (0.1%)"

1

Karimov, Aibulat, Rinat Gataullin, Ildar Zulkarnay, Vitaly Pechatkin, Marsel Nizamutdinov, and Pavel Ivanov, eds. Innovative technologies of management of socio-economic development of Russian regions: Proceedings of the XVII International Scientific and Practical Conference dedicated to the memory of Academician of the Academy of Sciences of the Republic of Bashkortostan, Doctor of Economics, Prof. Isyanbaev M.N. Part II. Institute of Social and Economic Researches - Subdivision of the Ufa Federal Research Centre of the Russian Academy of Science, 2025. https://doi.org/10.31040/978-5-6051264-3-0.

Full text
Abstract:
The conference is devoted to the topical problems of management of innovative development of multilevel territorial systems. Special attention is paid to the problems of increasing competitiveness and economic security of Russian regions in the conditions of new geopolitical realities (Section 1); modeling and management of innovative development of socio-economic systems in the conditions of new economic reality (Section 2); increasing financial sustainability of socio-economic development of regions in modern conditions (Section 3); sustainability management in the development of multilevel
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Topical Olopatadine (0.1%)"

1

O'Donnell, Judith A., Steven P. Gelone, and Amar Safdar. "Topical Antibacterials." In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier, 2015. http://dx.doi.org/10.1016/b978-1-4557-4801-3.00037-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thakker, Kailas, and Ryan Klein. "Drug release: topical products." In Specification of Drug Substances and Products. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-08-102824-7.00019-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Watterberg, Kristi L., and Olivier Baud. "Systemic and topical glucocorticoids to prevent BPD." In Tantalizing Therapeutics in Bronchopulmonary Dysplasia. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-12-818987-0.00001-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Combined Topical Index: Volumes I and II." In Technical Design Solutions for Theatre. Elsevier, 2002. http://dx.doi.org/10.1016/b978-0-240-80492-7.50019-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Menon, Mala, Richard N. Dalby, Isha Naik, Hemali Savla, and Kaveri Kalola. "Pulmonary, Nasal, and Topical Aerosol Drug Delivery Systems." In Remington. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-12-820007-0.00030-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Malathi, M., B. N. Vedha Hari, and D. Ramyadevi. "Polymeric nanocarriers for topical drug delivery in skin cream." In Nanocosmetics. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-12-822286-7.00006-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Karataş, Serçin, Onur Ceran, Ülkü Ülker, et al. "A Trend Analysis of Mobile Learning." In Mobile and Blended Learning Innovations for Improved Learning Outcomes. IGI Global, 2016. http://dx.doi.org/10.4018/978-1-5225-0359-0.ch013.

Full text
Abstract:
The aim of this study is to determine current tendencies regarding mobile learning in published research between 2010 and 2015. In this study, 221 articles collected from the Web of Science Core Collection database with SSCI index were examined by using the content analysis technique. In the analyses, eight criteria were used, namely; research technique, sampling size, sampling level, learning domain, topical domain, data collecting tool, data analysis method and mobile application development approach. The results suggest that the main tendencies under these categories were experimental metho
APA, Harvard, Vancouver, ISO, and other styles
8

Martins-Shannon, Janine, and Jason Ghibesi. "Redesigning Student’s Thinking Processes through Advanced Discussion Forums." In Cases on Critical and Qualitative Perspectives in Online Higher Education. IGI Global, 2014. http://dx.doi.org/10.4018/978-1-4666-5051-0.ch012.

Full text
Abstract:
This chapter addresses how a typical discussion board can transform the learning process into a collaborative environment that creates extended thinking processes promoting successful student outcomes. To illustrate a collaborative learning environment, teaching methodologies should focus on assisting a student to become diversified independent thinkers. Creating a diversified independent thinker infuses independent and cooperative critical analysis through varied topical issues.
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, Patriann, and Alex Kumi-Yeboah. "Exploring the Interstices of Literate, Linguistic, and Cultural Diversity." In Teacher Education. IGI Global, 2016. http://dx.doi.org/10.4018/978-1-5225-0164-0.ch072.

Full text
Abstract:
In this chapter, we examine an English-speaking Caribbean multilingual teacher's response to linguistic diversity by exploring his linguistic and literate experiences and responses to language in various geographical and social contexts. Through in-depth semi-structured topical interviews, we identified three distinct recursive “pathways” representative of the teacher's experiences. These pathways constituted his processes of attitude transformation, strategy use, and identity formation. The findings highlight the need for further exploration of multilingual teachers' linguistic diversity and
APA, Harvard, Vancouver, ISO, and other styles
10

Rahman, Mahfoozur, and Kainat Alam. "Graphene and its nanocomposites as antimicrobial potential in topical disease: state of the art." In Nanostructured Drug Delivery Systems in Infectious Disease Treatment. Elsevier, 2024. http://dx.doi.org/10.1016/b978-0-443-13337-4.00016-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Topical Olopatadine (0.1%)"

1

Varnhorn, W. "An Approximation Method for Non-Stationary Stokes Flow." In Topical Problems of Fluid Mechanics 2023. Institute of Thermomechanics of the Czech Academy of Sciences; CTU in Prague Faculty of Mech. Engineering Dept. Tech. Mathematics, 2023. http://dx.doi.org/10.14311/tpfm.2023.027.

Full text
Abstract:
We consider a rst order implicit time stepping procedure (Euler scheme) for the non-stationary Stokes equations in smoothly bounded domains of R³. Using energy estimates we can prove optimal convergence properties in the Sobolev spaces Hᵐ(G) (m = 0, 1, 2) uniformly in time, provided that the solution of the Stokes equations has a certain degree of regularity.
APA, Harvard, Vancouver, ISO, and other styles
2

Isoz, Martin, and Marie Plachá. "A Parallel Algorithm for Flux-Based Bounded Scalar Re-distribution." In Topical Problems of Fluid Mechanics 2022. Institute of Thermomechanics of the Czech Academy of Sciences, 2022. http://dx.doi.org/10.14311/tpfm.2022.013.

Full text
Abstract:
Let us assume a bounded scalar function ? : Q = I × ? ? ?0, 1?, I ? R, ? ? R3, where Q is an open bounded domain and its discrete counterpart ?h defined on a computational mesh Qh = Ih × ?h. The problem of redistribution of ?h over ?h ensuring the scalar boundedness while maintaining the invariance of R ?h ?h dV is surprisingly frequent within the field of computational fluid dynamics (CFD). The present contribution is motivated by the case arising from coupling Lagrangian particle tracking and particle deposition within ?h with Eulerian CFD computation. We propose an algorithm for ?h redistri
APA, Harvard, Vancouver, ISO, and other styles
3

Varnhorn, W. "Second Order Semi-Discretization for Unsteady Stokes Flow." In Topical Problems of Fluid Mechanics 2024. Institute of Thermomechanics of the Czech Academy of Sciences; CTU in Prague Faculty of Mech. Engineering Dept. Tech. Mathematics, 2024. http://dx.doi.org/10.14311/tpfm.2024.032.

Full text
Abstract:
We consider a second order implicit time stepping procedure for the unsteady Stokes equations in bounded domains of R3. Using energy estimates we prove optimal convergence properties in a series of Sobolev spaces Hm(G) (m = 0, 1, 2) uniformely in time, provided that the Stokes solution has a high degree of regularity uniformly in time. Here in the case of our second order method the solution of the Stokes equations has to satisfy a certain non-local compatibility condition at the parabolic boundary being virtually uncheckable for given data, which can be satisfied by a special initial construc
APA, Harvard, Vancouver, ISO, and other styles
4

Hrovat, Milan F., Karl-H. Grosse, and Richard Seemann. "Fabrication, Properties and Irradiation Performance of Molded Block Fuel Elements for HTGRs." In Fourth International Topical Meeting on High Temperature Reactor Technology. ASMEDC, 2008. http://dx.doi.org/10.1115/htr2008-58025.

Full text
Abstract:
The molded block fuel element (FE) also called monolith is a molded body, consisting of a substantially isotropic highly crystalline graphite matrix, fuel regions within the same matrix and cooling channels. The fuel regions contain the fuel in the form of coated particles which are well bonded to the remaining graphite matrix, so that both parts of the block form a monolithic structure. The monolith meets the requirements for the very high temperature reactors attaining helium outlet temperatures above 1000°C. To fabricate the molded blocks FE demonstration plant was erected and put into oper
APA, Harvard, Vancouver, ISO, and other styles
5

Können, G. P. "Why do the Supernumeraries of Secondary Rainbows Never Show up in Rainshowers?" In Meteorological Optics. Optica Publishing Group, 1986. http://dx.doi.org/10.1364/mo.1986.fb1.

Full text
Abstract:
At the last Topical Meeting, Fraser 1) offered an explanation for the paradoxical fact that supernumeraries of the primary rainbow are regularly visible in rainshowers, although the obvious broad droplet-size distribution should prevent such. The reason of their appearance is the flattened shape of falling drops, which causes the rainbow angle to increase with increasing (equivalent) drop-radius r, at least for solar heights h between 0 and 42°. Since therefore the positions of the Airy maxima as a function of r have a minimum, the supernumeraries still show up in rainshowers. However, the ang
APA, Harvard, Vancouver, ISO, and other styles
6

Nedelcu, Razvan-Ioan. "Study on the socio-affective climate of adolescent students." In The International Scientific Congress "Sports. Olimpysm. Health". SOH 2023. 8th Edition. The State University of Physical Education and Sport, 2025. https://doi.org/10.52449/soh23.40.

Full text
Abstract:
The problem under research is of particular importance for the family and society because we can say, without fear of being subjective, that the socialization of children, i.e. their preparation to live in society, is a very topical problem precisely by ignoring its systematic and conscious approach at the level of society , especially in the context where puberty is the period when sports activities are of vital importance for socialization. At this stage of life, the child is sensitive to cognitive and moral development, he assumes different roles, learns that he is different from others and
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Topical Olopatadine (0.1%)"

1

Chou, Roger, Azrah Y. Ahmed, Tracy Dana, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update. Agency for Healthcare Research and Quality (AHRQ), 2024. https://doi.org/10.23970/ahrqepccer250.2024update.

Full text
Abstract:
Objectives. To update the evidence on benefits and harms of cannabinoids and other plant-based compounds to treat subacute and chronic pain in adults and adolescents using a living systematic review approach. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases, and reference lists of included studies were searched to June 30, 2024. Review methods. We grouped studies based on their tetrahydrocannabinol (THC) to cannabidiol (CBD) ratio and by product type: synthetic, purified (plant-derived product consisting of a single cannabinoid, e.g., dronabinol or
APA, Harvard, Vancouver, ISO, and other styles
2

Chou, Roger, Azrah Y. Ahmed, Benjamin J. Morasco, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update. Agency for Healthcare Research and Quality, 2023. http://dx.doi.org/10.23970/ahrqepccer250update2023.

Full text
Abstract:
Objectives. To update the evidence on benefits and harms of cannabinoids and other plant-based compounds to treat sub-acute and chronic pain in adults and adolescents using a living systematic review approach. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases; and reference lists of included studies were searched to April 23, 2023. Review methods. An updated protocol with expanded inclusion criteria (addition of sub-acute [4 to 12 weeks’ duration] pain and adolescents) was posted on the PROSPERO registry. We grouped studies based on their THC to CBD
APA, Harvard, Vancouver, ISO, and other styles
3

McDonagh, Marian S., Jesse Wagner, Azrah Y. Ahmed, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain. Agency for Healthcare Research and Quality (AHRQ), 2021. http://dx.doi.org/10.23970/ahrqepccer250.

Full text
Abstract:
Objectives. To evaluate the evidence on benefits and harms of cannabinoids and similar plant-based compounds to treat chronic pain. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases, reference lists of included studies, submissions received after Federal Register request were searched to July 2021. Review methods. Using dual review, we screened search results for randomized controlled trials (RCTs) and observational studies of patients with chronic pain evaluating cannabis, kratom, and similar compounds with any comparison group and at least 1 month
APA, Harvard, Vancouver, ISO, and other styles
4

Chou, Roger, Jesse Wagner, Azrah Y. Ahmed, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for iii Chronic Pain: 2022 Update. Agency for Healthcare Research and Quality (AHRQ), 2022. http://dx.doi.org/10.23970/ahrqepccer250update2022.

Full text
Abstract:
Objectives. To update the evidence on benefits and harms of cannabinoids and similar plant-based compounds to treat chronic pain using a living systematic review approach. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases; reference lists of included studies; and submissions received after Federal Register request were searched to April 4, 2022. Review methods. Using dual review, we screened search results for randomized controlled trials (RCTs) and observational studies of patients with chronic pain evaluating cannabis, kratom, and similar compounds
APA, Harvard, Vancouver, ISO, and other styles
5

Chou, Roger, Azrah Y. Ahmed, Christina Bougatsos, et al. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 2. Agency for Healthcare Research and Quality (AHRQ), 2023. http://dx.doi.org/10.23970/ahrqepccer250.2022updatesr2.

Full text
Abstract:
Objectives. To update the evidence on benefits and harms of cannabinoids and similar plant-based compounds to treat chronic pain using a living systematic review approach. Data sources. Ovid® MEDLINE®, PsycINFO®, Embase®, the Cochrane Library, and SCOPUS® databases; reference lists of included studies; and submissions received after Federal Register request were searched to October 24, 2022. Review methods. Using dual review, we screened search results for randomized controlled trials (RCTs) and observational studies of patients with chronic pain evaluating cannabis, kratom, and similar compou
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Topical Olopatadine (0.1%)' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography